HPSE and cancer: However, OGT 2115 has been little studied, and It is clear from the emerging scientific literature that the specific molecular targets and actions of many drugs including the four drugs we specifically chose are not completely understood and that although, for instance, OGT 2115 is a heparanase inhibitor, that may in fact not be its major mechanism of action in cancer cells either in vitro or in vivo.